SIRT7 and prostate cancer: Indeed, the knockdown of SIRT7 led to the inhibition of the migration by 48% and 68 % in DU145 and PC3 respectively, suggesting that SIRT7 was implicated in prostate cancer cell migration and may participate in PCa aggressive phenotype.